M. Maasberg

506 total citations
15 papers, 330 citations indexed

About

M. Maasberg is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Maasberg has authored 15 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Maasberg's work include Lung Cancer Research Studies (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). M. Maasberg is often cited by papers focused on Lung Cancer Research Studies (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). M. Maasberg collaborates with scholars based in Germany and Switzerland. M. Maasberg's co-authors include K. Havemann, Gabriele Jaques, Martin Rotsch, Jürgen Hofmann, Ulrich Kaiser, R. Egbring, Hari S. Sharma, R. Pfab, Wolfgang Schäper and M. Wolf and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Biochemistry.

In The Last Decade

M. Maasberg

15 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Maasberg Germany	8	139	104	85	61	52	15	330
Mustafa Yaylacı Türkiye	10	49 0.4×	187 1.8×	98 1.2×	47 0.8×	49 0.9×	28	413
Morito Monden Japan	13	113 0.8×	37 0.4×	22 0.3×	28 0.5×	50 1.0×	20	373
Edelmiro Regañón Spain	13	159 1.1×	86 0.8×	20 0.2×	86 1.4×	91 1.8×	25	427
Elena Ninci Germany	9	107 0.8×	87 0.8×	18 0.2×	34 0.6×	28 0.5×	10	324
Vera Tiedje Germany	11	125 0.9×	204 2.0×	338 4.0×	52 0.9×	72 1.4×	24	511
N Peyri France	12	93 0.7×	85 0.8×	9 0.1×	74 1.2×	23 0.4×	15	322
AM Randi United Kingdom	5	154 1.1×	24 0.2×	26 0.3×	46 0.8×	31 0.6×	9	428
Mariam Jafri United Kingdom	8	87 0.6×	64 0.6×	100 1.2×	124 2.0×	102 2.0×	15	354
Kiyoaki Inoue Japan	5	285 2.1×	61 0.6×	33 0.4×	99 1.6×	68 1.3×	9	524

Countries citing papers authored by M. Maasberg

Since Specialization

Citations

This map shows the geographic impact of M. Maasberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Maasberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Maasberg more than expected).

Fields of papers citing papers by M. Maasberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Maasberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Maasberg. The network helps show where M. Maasberg may publish in the future.

Co-authorship network of co-authors of M. Maasberg

This figure shows the co-authorship network connecting the top 25 collaborators of M. Maasberg. A scholar is included among the top collaborators of M. Maasberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Maasberg. M. Maasberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Grünwald, Viktor, Martin Boegemann, Günter Niegisch, et al.. (2022). Final analysis of a non-interventional study on cabozantinib in patients with advanced renal cell carcinoma after prior checkpoint inhibitor therapy (CaboCHECK).. Journal of Clinical Oncology. 40(6_suppl). 357–357. 1 indexed citations

Chakupurakal, Geothy, M. Maasberg, Burkhard Otremba, et al.. (2019). High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany. Supportive Care in Cancer. 27(11). 4265–4271. 5 indexed citations

Weide, Rudolf, et al.. (2017). Standard of care of patients with Chronic Myeloid Leukemia (CML) treated in community based oncology group practices between 2001-2015 in Rhineland-Palatinate (Germany). SHILAP Revista de lepidopterología. 37(1). 2 indexed citations

Diel, Ingo, et al.. (2010). Bone pain reduction in patients with metastatic breast cancer treated with ibandronate–results from a post-marketing surveillance study. Supportive Care in Cancer. 18(10). 1305–1312. 8 indexed citations

Hofmann, Jürgen, Ulrich Kaiser, M. Maasberg, & K. Havemann. (1995). Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines. European Journal of Cancer. 31(12). 2053–2058. 38 indexed citations

Rüschoff, Josef, Karl H. Plate, Ralf Müller, M. Maasberg, & C. Thomas. (1993). Nucleolar Organizer Region-Associated Proteins: A Diagnostic Tool in Cytology?. Recent results in cancer research. 133. 81–89. 1 indexed citations

Seitz, Rainer, Michael Kraus, M. Wolf, et al.. (1993). Activation of coagulation and fibrinolysis in patients with lung cancer. Blood Coagulation & Fibrinolysis. 4(2). 249–254. 71 indexed citations

Maasberg, M., et al.. (1993). Activators of coagulation in cultured human lung‐tumor cells. International Journal of Cancer. 53(3). 514–520. 15 indexed citations

Rotsch, Martin, et al.. (1992). Characterization of insulin-like growth factor I receptors and growth effects in human lung cancer cell lines. Journal of Cancer Research and Clinical Oncology. 118(7). 502–508. 42 indexed citations

10.

Wolf, M., M. Maasberg, R. Pfab, & K. Havemann. (1991). Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell lines. Journal of Cancer Research and Clinical Oncology. 117(S4). S187–S192. 3 indexed citations

11.

Schroeder, M., et al.. (1991). Application of the dihydropyridine derivate B8509-035 in resistent Small Cell Lung Cancer (SCLC). Lung Cancer. 7. 140–140. 1 indexed citations

12.

Maasberg, M., et al.. (1989). Androgen receptors, androgen‐dependent proliferation, and 5α‐reductase activity of small‐cell lung cancer cell lines. International Journal of Cancer. 43(4). 685–691. 34 indexed citations

13.

Maasberg, M., et al.. (1989). Isolation of heparin‐binding growth factors from bovine, porcine and canine hearts. European Journal of Biochemistry. 181(1). 67–73. 51 indexed citations

14.

Jaques, Gabriele, et al.. (1988). Production of immunoreactive insulin-like growth factor I and response to exogenous IGF-I in small cell lung cancer cell lines. Experimental Cell Research. 176(2). 336–343. 55 indexed citations

15.

Wolf, M., C. Gropp, M. Maasberg, et al.. (1988). Ergebnisse zweier multizentrischer Therapiestudien beim inoperablen nichtkleinzelligen Bronchialkarzinom. Oncology Research and Treatment. 11(5). 222–231. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact